Clinical Trial Update: Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing gemcitabine plus cisplatin vs gemcitabine plus paclitaxel in triple-negative breast cancer has completed. The record notes the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED